MTTlab and Giotto Biotech – new commercial collaboration
MTTlab and Giotto Biotech have entered into a collaboration to expand their respective services portfolio in the field of preclinical drug development.
Thanks to this new cooperation, Giotto Biotech and MTTlab will be able to widen their expertise and launch new services and product offers.
About Giotto Biotech
Giotto Biotech S.r.l. is a research-intensive, small‐medium enterprise (SME), aiming to contribute to the biotech sciences by providing enabling products and services, with a special focus on technologies complementary to the field of nuclear magnetic resonance (NMR).
The company is active in several areas including protein production and labeling (a “custom” production service for proteins is available), organic synthesis, NMR services, and information technologies. The NMR services include metabolomics and statistical analysis.
MTTlab delivers both in vitro and in vivo data sets for the preclinical evaluation of investigational compounds which can be used for regulatory submissions, project evaluation, scientific publications and fund raising. MTTlab provides support for client studies or projects from the earliest research stages and assists with both scientific and regulatory challenges to obtain valid results within requested deadlines.